Search bioRxiv⌕ Search

Biology subjects

Pascual, N. S.

Publications and source records attributed to Pascual, N. S..

2 recordsLinked to original sources

EvoSeq-ML: Advancing Data-Centric Machine Learning with Evolutionary-Informed Protein Sequence Representation and Generation

From protein structure prediction to novel protein generation, challenging protein engineering tasks have been made possible by advancements in machine learning (ML). While largely driven by ML architecture refinements, these advancements in ML-based protein engineering campaigns have left the impact of data curation underexplored. In light of the growing wealth of labeled sequence data, data-centric advances (e.g. prioritizing improvements in ML protein engineering tools through the curation of high-quality, domain-specific training data) are increasingly preferred over model-centric advancements. Implementing datasets that accurately reflect biological complexity and diversity has been shown to improve the efficiency of training protein engineering ML tools. Here, we evaluate an ancestral sequence reconstruction (ASR)-informed data augmentation strategy for training generative and representation-learning models in protein engineering. Using ethylene-forming enzyme (EFE) as a model system, we show that variational autoencoder models trained on ancestral and near-ancestral sequence datasets generate variants with improved predicted and experimentally measured thermostability relative to variants generated from modern-sequence training data. All experimentally tested ancestral and ML-generated EFEs produced detectable ethylene, although ML-generated variants showed reduced activity relative to wild-type EFE, indicating that the approach more strongly captured stability-associated features than catalytic optimization. We further evaluated ASR-enriched sequence sets for fine-tuning ESM2 representations in endolysin and lysozyme C stability-classification tasks, where ancestral representations were competitive with modern-sequence fine-tuning in selected settings. Overall, this work supports ASR-informed data augmentation as a promising strategy for stability-oriented protein sequence generation and motivates future work to couple ancestral sequence diversity with explicit functional selection.

bioinformatics↗

Predicting Inhibitors of OATP1B1 via Heterogeneous OATP-Ligand Interaction Graph Neural Network (HOLI-GNN)

Organic anion transporting polypeptides (OATPs) are membrane transporters crucial for drug uptake and distribution in the human body. OATPs can mediate drug-drug interactions (DDIs) in which the interaction of one drug with an OATP impairs the uptake of another drug, resulting in potentially fatal pharmacological effects. Predicting OATP-mediated DDIs is challenging, due to limited information on OATP inhibition mechanisms and inconsistent experimental OATP inhibition data across different studies. This study introduces Heterogeneous OATP-Ligand Interaction Graph Neural Network (HOLIgraph), a novel computational model that integrates molecular modeling with a graph neural network to enhance the prediction of drug-induced OATP inhibition. By combining ligand (i.e., drug) molecular features with protein-ligand interaction data from rigorous docking simulations, HOLIgraph outperforms traditional DDI prediction models which rely solely on ligand molecular features. HOLIgraph achieved a median balanced accuracy of over 90 percent when predicting inhibitors for OATP1B1, significantly outperforming purely ligand-based models. Beyond improving inhibition prediction, the data used to train HOLIgraph can enable the characterization of protein residues involved in inhibitory drug-OATP interactions. We identified certain OATP1B1 residues that preferentially interact with inhibitors, including I46 and K49. We anticipate such interaction information will be valuable to future structural and mechanistic investigations of OATP1B1. Scientific ContributionHOLIgraph introduces a new paradigm for DDI prediction by incorporating protein-ligand interactions derived from docking simulations into a graph neural net framework. This approach, enabled by recent structural breakthroughs for OATP1B1, represents a significant departure from traditional models that rely only on ligand features. By achieving high predictive accuracy and uncovering mechanistic insights, HOLIgraph sets a new trajectory for computational tools in drug design and DDI prediction.

bioengineering↗